News for Charles River Laboratories Stock (CRL)

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience

Business Wire • 09/04/24

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Business Wire • 09/03/24

CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories' Directors and Officers for Breach of Fiduciary Duties

GlobeNewsWire • 08/22/24

Charles River Laboratories: Changing Economics Reduces Compounding Ability (Rating Downgrade)

Seeking Alpha • 08/15/24

CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

GlobeNewsWire • 08/14/24

Why Charles River (CRL) International Revenue Trends Deserve Your Attention

Zacks Investment Research • 08/12/24

Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)

Seeking Alpha • 08/10/24

Charles River (CRL) Q2 Earnings Beat Estimates, 2024 View Down

Zacks Investment Research • 08/07/24

Charles River Laboratories International Inc (CRL) Q2 2024 Earnings Call Transcript

Seeking Alpha • 08/07/24

Charles River Labs Says It Expects Sales To Fall, Sending Its Stock Tumbling

Investopedia • 08/07/24

Here's What Key Metrics Tell Us About Charles River (CRL) Q2 Earnings

Zacks Investment Research • 08/07/24

Charles River Laboratories Stock Sinks As It Warns Of Continued Biotech Demand Slump, Lowers Forecast

Benzinga • 08/07/24

Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024

Investors Business Daily • 08/07/24

Charles River Laboratories (CRL) Surpasses Q2 Earnings and Revenue Estimates

Zacks Investment Research • 08/07/24

Charles River cuts 2024 forecast as funding crunch among biotech clients persists

Reuters • 08/07/24

Charles River Laboratories Announces Second-Quarter 2024 Results

Business Wire • 08/07/24

Unlocking Q2 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics

Zacks Investment Research • 08/05/24

Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development

Business Wire • 07/30/24

Here's How Charles River (CRL) is Placed Ahead of Q2 Earnings

Zacks Investment Research • 07/24/24

Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery

Business Wire • 07/24/24

Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call

Business Wire • 07/16/24

Charles River (CRL) Teams Up to Aid Stargardt's Disease Therapy

Zacks Investment Research • 07/09/24

Charles River to Perform Plasmid Manufacturing for AAVantgarde

Business Wire • 07/08/24

Charles River (CRL) Could be an Apt Pick Right Now: Here's Why

Zacks Investment Research • 07/05/24

Charles River's (CRL) RMS Growth Aids Amid FX Headwind

Zacks Investment Research • 06/27/24